Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 4/1999

Content (13 Articles)

ORIGINAL ARTICLE

Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines

William C. Zamboni, Peter J. Houghton, Jeff L. Hulstein, Mark Kirstein, Jessica Walsh, Pam J. Cheshire, Suzan K. Hanna, Mary K. Danks, Clinton F. Stewart

ORIGINAL ARTICLE

Aerosol delivery of liposomal all-trans -retinoic acid to the lungs

Ranjani Parthasarathy, Brian Gilbert, Kapil Mehta

ORIGINAL ARTICLE

Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent

Noriaki Tatsuta, Naomi Suzuki, Takae Mochizuki, Keizo Koya, Masayuki Kawakami, Tadao Shishido, Naomi Motoji, Hiroyuki Kuroiwa, Akiyo Shigematsu, Lan Bo Chen

ORIGINAL ARTICLE

Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients

Bruno Reigner, Saly Clive, Jim Cassidy, Duncan Jodrell, Rainer Schulz, Timothy Goggin, Ludger Banken, Brigitte Roos, Masahiro Utoh, Thomas Mulligan, Erhard Weidekamm

ORIGINAL ARTICLE

A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients

Brigitte Tranchand, Carole Amsellem, Etienne Chatelut, Gilles Freyer, Athanassios Iliadis, Blandine Ligneau, Véronique Trillet-Lenoir, Pierre Canal, Isabelle Lochon, Claude Joseph Ardiet

ORIGINAL ARTICLE

Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat and rabbit

Philip Kestell, James W. Paxton, Gordon W. Rewcastle, Ingrid Dunlop, Bruce C. Baguley

ORIGINAL ARTICLE

Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin

Katerina Dvorakova, Robert T. Dorr, Susanne Valcic, Barbara Timmermann, David S. Alberts

ORIGINAL ARTICLE

Polyamine analog bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) enhances simian virus 40 late gene expression

Hirak S. Basu, Nancy Dreckschmidt, Linh Tu, Lisa Chanbusarakum

ORIGINAL ARTICLE

Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines

Anna Lokshin, Xiaojun Peng, Phil G. Campbell, Alexander Barsouk, Mark L. Levitt

ORIGINAL ARTICLE

Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma

Paola Aita, Isabelle Robieux, Roberto Sorio, Salvatore Tumolo, Giuseppe Corona, Renato Cannizzaro, Anna Maria Colussi, Mauro Boiocchi, Giuseppe Toffoli

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine